Biotechnology Assets, S.A. (BST:041)
Germany · Delayed Price · Currency is EUR 0.1775
+0.0005 (0.28%)
At close: Jan 15, 2026
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €13.55 million as of January 16, 2026. Its market cap has decreased by -25.89% in one year.
Market Cap
13.55M
Enterprise Value
15.11M
Revenue
3.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 13.55M, a decrease of -81.85%. That is a compound annual growth rate of -20.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 13.58M | -2.81% |
| Dec 31, 2025 | 13.98M | -23.55% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 239.44B |
| Siemens Aktiengesellschaft | 202.69B |
| Allianz SE | 145.29B |
| Deutsche Telekom AG | 132.38B |
| Siemens Energy AG | 109.66B |
| Rheinmetall AG | 87.79B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.11B |
| Deutsche Bank Aktiengesellschaft | 64.28B |